Optimal cumulative dose of cabergoline does not appear to cause fibrotic pulmonary side effects in prolactinoma
22 nd European Congress of Endocrinology (ECE) 2020, 5 - 09 September 2020, pp.1-3, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Page Numbers: pp.1-3
- Istanbul University Affiliated: Yes